Guide

Essential guide to cell and gene therapy (CGT)  commercialization

Six considerations when bringing your new product to market


Having devoted your time, expertise, and financial resources to the development of a transformative cell or gene therapy that improves patients’ lives, ensuring that patients can truly reap the benefits of your innovation is essential.

Unlock the full potential of your product and make the most of your investments by following this step-by-step guide to commercialization

Download the guide to get:

  • Valuable insights to help you navigate the market and maximize the impact of your therapy
  • Six key considerations for commercializing your CGT asset, from patient access and support, to regulations, logistics and supply chain, commercial distribution, and more

cgt

Pardot Form

Related resources

doctor-ai-in-managed-care-trends-report-vea

Report

Artificial intelligence in managed care: Trends from 2024 to 2026

Webinar

The policy agenda: Key global policy shifts for 2027

Article

CMC reality check: Late-stage risks that impact approval

Connect with our cell and gene experts

Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
Abstract